Long Non-Coding Rnas (Lncrnas) In The Pathogenesis Of B Cell Lymphomas

Universities and Institutes of Czech

Czech Republic

October 31, 2022

Description

  • Organisation/Company: Masaryk University, Faculty of Medicine
  • Research Field: Medical sciences › Medicine
  • Researcher Profile: First Stage Researcher (R1)
  • Application Deadline: 31/10/2022 00:00 - Europe/Brussels
  • Location: Czech Republic
  • Offer Starting Date: 01/03/2023
  • We are looking for a motivated PhD student that would like to work on the following project funded by the ERC (European Research Council) Starting grant. Follicular lymphoma (FL) is a type of blood cancer that originates from B-lymphocytes, and it is the most common type of indolent non-Hodgkin lymphoma. The clinical course of FL patients can be surprisingly variable (survival from months to decades) and FL still remains incurable. The course of the disease is characterized by repeated relapses leading to the evolution of resistant disease or to the high-grade transformation to a more aggressive diffuse large B-cell lymphoma (DLBCL). This is associated with remarkably poor prognosis and a high risk of early death. Number of studies showed that multiple genetic lesions are associated with FL transformation (tFL); however, precise molecular mechanisms underlying this process is largely unclear. Importantly, the role of long non-coding RNAs in this process is completely unknown. However, we have recently described the role of short- noncoding miRNAs roles in transformed FL (Musilova et al…Mraz, Blood, 2018). The aim of the project is to reveal the molecular mechanisms involving lncRNAs and/or miRNAs responsible for FL transformation. The primary samples collected before and after high-grade transformation will be analyzed on the level of protein-coding as well as non-coding genes (NGS with Illumina, preliminary data available). This will be followed by searching for function of tFL- associated lncRNAs. This will help to better understand the disease biology and possibly to identify novel molecular targets that could be used therapeutically. Recommended literature: Sharma et al. …Mraz. miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors. Blood 2020 Nov (epub). https: // pubmed.ncbi.nlm.nih.gov/33171493/ Musilova et al. …Mraz. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels . BLOOD. 2018 NOV 29;132(22):2389-2400. https: // pubmed.ncbi.nlm.nih.gov/33786575/ Musilova K, Mraz M. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia. 2015 May;29(5):1004-17Zeni and Mraz LncRNAs in adaptive immunity: role in physiological and pathological conditions. RNA Biol. 2021 May;18(5):619-632. https: // pubmed.ncbi.nlm.nih.gov/33094664/ Funding: Part-time salary (min. 0,5 FTE) on AZV/ERC/GACR grants + national scholarship (equals approx. half-time salary) Requirements on candidates: • Motivated smart people that have the “drive” to work independently, but also willing to learn from other people in the lab and collaborate. • Candidates should have a master's degree in Molecular biology, Biochemistry, or similar field and have deep interest in molecular biology and cancer cell biology. Keywords: Long non-coding RNA, lymphomas, DLBCL, miRNA Number of positions: 1 Information on the supervisor: H-index 22 (citations at WOS > 1600, 46 publications with IF), currently principal investigator of 4 fundings (AZV, ERC, GAMU, NPÚ), international collaborations: University of Southampton, UCSD, Mayo Clinic, Dana-Farber Cancer Institute, EMBL, University of Turin (student internship available), member of EHA Committee, a reviewer in scientific journals: Blood, Leukemia, Leuk Lymphoma, Leukemia Research; https: // is.muni.cz/auth/osoba/101627; ceitec.cz/mrazlab

    Contact Information
  • Organisation/Company: Masaryk University, Faculty of Medicine
  • Organisation Type: Higher Education Institute
  • Country: Czech Republic
  • Similar Jobs

    Add to favorites Read more...

    Cdd – Post Phd Student H/F

    Research Field: Biological sciences › Biology Pharmacological sciences › Location: France › Paris accelerate research by organizing it as close as possible to the patient in Project description: Targeting Anaplasic Large Cell Lymphoma cells with...

    Cancer Research UK

    United Kingdom 3 days ago

    Add to favorites Read more...

    PhD studentship - Sara Zanivan

    Tumour microenvironment and metabolism the TME and influence the behaviour of cancer cells and blood vessels (Kay et question to find ways to target CAFs to oppose tumour-promoting functions of Altered cell metabolism is a...

    Add to favorites Read more...

    Post-Doctoral Fellowship - Acute Myeloid Leukemia - Perugia, Italy

    Research Field: Biological sciences › Biology Location: Italy › Perugia biology and treatment of NPM1-mutated acute myeloid leukemia. Unfortunately, most patients diagnosed with NPM1-mutated AML eventually role in the maintenance of the leukemic phenotype of...

    Add to favorites Read more...

    Rif. 5379 - Innovative Approaches To Diagnosis, Monitoring And Treatment Of Lymphomas And Chronic...

    Research Field: Medical sciences Location: Italy › Bologna minimal residual disease after an effective treatment. bispecific antibodies in patients with heavily pretreated B-cell lymphomas; patients with hairy cell leukemia and correlation with overall survival and...

    Katholieke Universiteit Leuven

    Belgium Sep 23, 2022

    Add to favorites Read more...

    Ph.D. in computational methods for cancer multi-omics

    Ph.D. in computational methods for cancer multi-omics Department of Oncology at KU Leuven accomodates around 400 researchers in 25 research groups and is one of the global leaders in several fields of cancer research, including...

    Katholieke Universiteit Leuven

    Belgium Sep 22, 2022

    Add to favorites Read more...

    Ph.D. in computational methods for cancer multi-omics

    Ph.D. in computational methods for cancer multi-omics Department of Oncology at KU Leuven accomodates around 400 researchers in 25 research groups and is one of the global leaders in several fields of cancer research, including...